The potential of incorporating a real-time PCR for amplification and detection of 16S rRNA gene signatures directly from clinical samples was assessed as a tool for diagnostics. Universal PCR primers spanning short variable regions (~500 bp) were optimized for real-time PCR and tested in comparison with a longer fragment (~1400 bp) generated from block-based amplification. Real-time PCR had improved sensitivity of detection (8 % increase), decreased amplification time and simplified downstream processing. The real-time PCR primers also offered an improvement in detection of bacteria from samples that demonstrated inhibition with the block-based primers and in the resolution of mixed-sequence traces. In addition to testing primer sensitivity, the effect of amplifying and sequencing two different variable regions of the 16S rRNA gene on organism identification was compared. By amplifying and sequencing a shorter variable region, the number of species that were identified to the species level was reduced by 18 %.
INTRODUCTION
16S rRNA gene amplification and sequencing has been well documented as a useful tool for detection and identification of bacteria (Bosshard et al., 2003; Drancourt et al., 2000; Mignard & Flandrois, 2006; Tang et al., 1998; Woo et al., 2008) . Several strategies and targets have been used based on the utility of the entire gene or specifically targeting one or more variable regions within the gene. As well as proving fundamental in taxonomy, where 16S rRNA gene sequencing has been used repeatedly to clarify relationships within a wide range of taxa (Snel et al., 1999 : Stackebrandt & Goebel, 1994 , the 16S rRNA gene has also been used as a tool for probing the diversity of microbial communities (Baker et al., 2001; Hill et al., 2000; Hohn et al., 2002) . Here, it was used to identify both cultivable and uncultivable bacteria, the latter due to difficulty in mimicking the environmental habitats and nutritional requirements of these organisms in the laboratory. Similar studies have resulted in the discovery of several new taxonomic groups through direct amplification of 16S rRNA gene fragments (Drancourt et al., 2000 (Drancourt et al., , 2004 Woo et al., 2008) .
With the increase in molecular methods and supporting technologies in laboratories, the use of 16S rRNA gene PCR and sequencing has been exploited in clinical microbiology.
Initially, this was used for the identification of bacterial isolates (Bosshard et al., 2003; Drancourt et al., 2004; Mignard and Flandrois, 2006; Zucol et al., 2006) but increasingly has been employed for direct detection in clinical samples and in particular the analysis of culturenegative samples (Harris & Hartley, 2003; Heikens et al., 2005; Kommedal et al., 2009; Zucol et al., 2006) . Direct detection has allowed identification of bacteria that have not survived transportation, are suppressed by antibiotic treatment and have complex growth requirements. Several groups have published methodologies for block-based analysis (also known as end-point analysis) of different sample types and have reported the advantages and pitfalls of using 16S rRNA gene PCR and sequencing (Corless et al., 2000; Janda & Abbott, 2007; Millar et al., 2002) . Unlike realtime PCR, block-based assays require agarose gel electrophoresis to visualize the PCR product.
Real-time PCR offers many advantages for detection of the 16S rRNA gene from clinical samples. For other gene targets, real-time PCR has demonstrated increased sensitivity over block-based assays (Apfalter et al., 2003; Desjardin et al., 1998; Lienard et al., 2011) , which could be vital when detecting low numbers of bacteria in culturenegative samples. Analysis can be semi-quantitative, as there is a direct correlation between the amount of starting material and the threshold crossing point (CP), which is more informative than visualizing the products on an agarose gel (Ririe et al., 1997) . The speed of amplification in real-time PCR is generally faster than a block-based approach and it is not necessary to use agarose gel electrophoresis to visualize the products. This reduces the overall processing time, which in turn may have a positive impact on patient care. The aim of this study was to increase sensitivity, speed of amplification and speed/ease of use of downstream processing. In this paper, we report our findings using a LightCycler (LC; Roche) for amplification of two alternative 500 bp 16S rRNA gene fragments covering different variable regions and comparison of these with a block-based assay (amplifying a 1400 bp fragment) currently used in our laboratory. Bacterial identification resulting from sequencing the different variable regions was also assessed.
METHODS

Samples.
A total of 213 samples from normally sterile sites and clinically suspected to contain an infectious agent were used in this study. Of these, 56 % were culture-negative and 13 % were culturepositive (i.e. an isolate was also recovered from the sample), whilst for the remainder (31 %), culture information was not provided. The range of sample types tested in the study is detailed in Table 1. DNA extraction. Genomic DNA was extracted from all samples using a DNeasy Blood and Tissue kit (Qiagen). For different sample types, pre-treatment and lysis steps were performed (as detailed below), followed by standard extraction using the manufacturer's instructions. For tissue samples, one to three pieces of tissue approximately 2-3 mm 2 were placed in a sterile tube, proteinase K solution (Qiagen) and ATL buffer (Qiagen) were added and the tubes were incubated overnight at 56 uC. Following standard extraction, the tissue samples were resuspended in 50 ml nuclease-free water. Up to 200 ml of liquid samples was used, and if necessary the sample volume was made up to 200 ml using PBS. The samples were extracted using a standard protocol but were eluted in half of the starting volume (but not less than 50 ml) with nuclease-free water. For liquid samples that could not be pipetted (e.g. pus), a portion~4 mm in diameter was placed into a sterile tube, proteinase K solution and ATL buffer were added and the tube was incubated overnight at 56 uC. After extraction using a standard Qiagen protocol, the DNA was resuspended in 50 ml nuclease-free water. For samples that had been fixed in wax, either a 3 mm 2 piece of tissue, with as much wax as possible removed, or four to five shavings were placed into a sterile tube and 1.2 ml UltraClear solution (TAAB Laboratories) was added. The tubes were centrifuged at 16 000 g for 5 min and the supernatant removed. The UltraClear wash was repeated and 1.2 ml ethanol (96-100 %) was added to the pellet to remove residual UltraClear. The tubes were vortexed and centrifuged at 16 000 g for 5 min, the ethanol was removed and the ethanol wash repeated. The pellet was resuspended in proteinase K solution and buffer AL (Qiagen) and the extraction was completed as described above. The samples were resuspended in 50 ml nuclease-free water. From a blood culture bottle, 200 ml fluid was placed into a sterile tube and 100 ml lysis buffer [5 M guanidine hydrochloride in 100 mM Tris/HCl (pH 8.0)], 400 ml sterile nuclease-free water and 800 ml 99 % benzyl alcohol were added (Fredricks & Relman, 1998) . Tubes were centrifuged at 7000 g for 5 min and 400 ml aqueous phase was transferred to a fresh tube. To this, 40 ml 3 M sodium acetate and 440 ml 2-propanol were added and the tubes were centrifuged at 16 000 g for 15 min. The supernatant was removed and 1 ml 70 % ethanol was added to the pellet. The tubes were centrifuged at 16 000 g for 5 min and the supernatant removed. To reduce the time required for air drying the precipitated DNA, the pellet was washed and eluted through a Qiagen DNeasy spin column as follows: the pellet was resuspended in 50 ml molecular biology-grade water and this was added directly to the column. After incubation at room temperature for 5 min, the column was centrifuged at 6000 g for 1 min and the eluate transferred to a fresh tube (Hogg et al., 2008) . A negative extraction control (200 ml PBS) was included in each extraction run. Following processing, the extracts were stored at 220 uC. Primers. The primers used for PCR and sequencing are detailed in Table 2 .
Block-based PCR. The PCR mixture consisted of 25 ml Go-Taq Green mastermix (Promega), 0.2 mM each of primers ANT1F and 1392R, 22 ml molecular biology-grade water and 1 ml extracted DNA. The mixture was amplified using an ABI 9700 PCR instrument using the following cycling conditions: denaturation at 95 uC for 2 min and 35 cycles of 95 uC for 45 s, 56 uC for 45 s and 72 uC for 1 min. A final extension was performed at 72 uC for 5 min. PCR products were separated by electrophoresis on a 2 % ethidium bromide stained E-gel (Life Technologies) following the manufacturer's instructions and were visualized by UV transillumination.
Real-time PCR. Real-time PCR was performed using a LC 2.0 in glass capillaries (Roche) or a LC 480 in an optical 96-well plate (Roche). The reaction mix consisted of 10 ml TaKaRa Ex Taq (Lonza), 0.4 mM each primer, 4.4 ml molecular biology-grade water and 2 ml extracted sample. The TaKaRa Ex Taq master mix contained SYBR Green I, which was used for real-time monitoring and detection of PCR products. Two sets of primers were used in the study, the first used forward CLSI and reverse Bosshard (Bosshard LC assay) (Table  2) PCR controls. Each PCR run included a positive control containing 1 ml Escherichia coli DNA at 50 ng ml 21 (Sigma) in the block-based assay or 1 ml E. coli DNA at 50 pg ml 21 (Sigma) in the LC assays, and a negative control of molecular biology-grade water. Extraction negative controls were also amplified. To control for PCR inhibition, a second PCR was performed where an identical reaction mix was spiked with 1 ml E. coli DNA at 1 ng ml 21 for the block-based assay or 0.5 pg ml 21 for the LC assays. For any reactions where amplification was not observed in either the extract or the spiked sample, the original nucleic acid template was diluted 1 : 10 and the PCR repeated.
Sequencing. The LC 2.0 reactions were spun out of the glass capillary into a 1.5 ml Eppendorf tube and these and the LC 480 reactions were transferred to an optical 96-well plate (Life Technologies). All PCR products were purified for sequencing using Agencourt Ampure beads (Beckman Coulter) using an NXP Biomek Robot following the manufacturer's protocol (Beckman Coulter). The samples were resuspended in a total volume of 40 ml molecular biology-grade water with 30 ml transferred by the robot to a new 96well plate for the sequencing set-up. The block-based PCRs were sequenced using primers 357F and 3R, the Bosshard LC products were sequenced using Bosshard forward and reverse primers, and the Kommedal LC products were sequenced with the Kommedal forward and reverse primers ( Table 2) . Sequencing reactions were performed using an ABI Prism 1.1 or 3.1 Big Dye sequencing kit and analysed on an ABI 3730 DNA Analyzer (Life Technologies).
Identification. Bacterial identification was made by forming contigs of forward and reverse sequences and comparing the contig consensus sequence with sequences in GenBank using the NCBI BLAST algorithm (Altschul et al., 1990) . Criteria of 98 % sequence identity and fewer than 5 bp different were considered sufficient to identify the organism to the species level (Harris & Hartley, 2003) . If species-level identification was not possible, then genus-level identification was made. Identification was confirmed by comparison of the sequence data with the ribosomal database project (http://rdp.cme.msu.edu/) using the Seq match analysis tool and using the same analysis criteria as above (Cole et al., 2007 (Cole et al., , 2009 ).
RESULTS
For phase 1 of the study, extracts were prepared from a total of 142 samples and amplified using the block-based assay. Of these samples, 43 were positive and 99 were negative. Nucleic acid extracts were stored at 220 u C and subsequently retested using real-time LC PCR over a time period of up to 2 years following the original extraction. For this, two amplicons were generated separately corresponding to two different variable (V) regions within the 16S rRNA gene. The Bosshard-based primers, which amplified the region spanning V1-V3, resulted in 54 positive samples and 88 negative samples. The Kommedalbased primers, which amplified regions V3-V4, detected 49 positive and 93 negative samples. Nine of the samples detected using LC PCR and not detected using block-based PCR showed a CP greater than cycle 26, which indicates a weak sample with a low amount of bacterial DNA present, and two samples contained substances that were inhibitory (Table 3 ).
In phase 1 of the study, the Bosshard-based primers amplifying V1-V3 resulted in more positive samples (4 % increase) and more species-level identifications (6 % increase) than the Kommedal-based primers (amplifying V3-V4) and as a result were selected for phase 2 of the study. In this phase, a blind comparison was made by testing a further 71 samples by both block-based primers and the Bosshard-based primers, with both PCRs being performed at the same time rather than retrospectively. The block-based primers resulted in 16 positives compared with 23 using the Bosshard-based primers; both also detected one mixed sample and the remainder of the samples were negative. The Bosshard-based primers detected six samples not amplified by the block-based primers, all of which were weak positives as indicated by the LC CP. As before, this demonstrated the increased sensitivity afforded by the smaller PCR product and use of real-time PCR. Amplifying and sequencing across V1-V9 resulted in ten (62 %) species-level identifications and six (38 %) genus-level identifications, whereas amplifying and sequencing V1-V3 resulted in ten (44 %) species-level identifications and 12 (52 %) genus-level identifications, with one (4 %) sample unidentified ( 
DISCUSSION
Using the LC for amplification of 16S rRNA gene signatures directly from clinical samples improved assay sensitivity, decreased the overall time taken to perform the test and simplified the downstream processing. The LC assays resulted in identifying more positive samples than the block-based assay, and this improvement in sensitivity could partly be attributed to the decrease in product size. A smaller amplicon size generally improves the PCR efficiency, as there is less depletion of the PCR components, e.g. Taq enzyme or dNTPs, resulting in an assay that is more sensitive. During amplification of smaller amplicons, there is less likelihood of secondary structures forming that can reduce efficiency by impairing transcription, and there are more complete products produced during each cycle of PCR, both of which contribute to the increased efficiency and sensitivity. A decrease in assay time can only be achieved by targeting a smaller product; larger products can be amplified on the LC but the hold times used cannot be reduced and overall time remains comparable to block-based amplification. The LC amplification was completed in 1 h compared with 2.5 h for the block-based amplification, plus a further reduction in processing time as an agarose gel was not required to visualize the products. Amplification was observed on the LC as a curve, and the software calculated the CP of when the amplicon amount exceeded the background threshold and could be detected. This CP value was directly correlated with the amount of starting material in the sample and could be used to provide information on the subsequent amount of template for sequencing plate preparation and for result calling. In this study, 36 % of the positive samples amplified with a CP value of ,20 cycles, which indicates a large amount of bacterial DNA present in the extract (corresponding to a strong band on an agarose gel), and 14 % of the positive samples were amplified with a CP value of .27, which indicates a very low level of bacterial DNA in the sample.
Three of the extracts produced amplicons only by LC PCR but required tenfold dilution before amplification was observed. The original extracts and the dilutions demonstrated inhibition (a second reaction spiked with E. coli DNA did not produce an amplicon) with the block-based PCR. All three extracts were from sample types known to cause problems due to PCR inhibitors (e.g. chemicals such as sodium polyanetholesulfonate), blood culture fluid and paraffin-embedded tissue (Akane et al., 1994; Fredricks & Relman, 1998; Holodniy et al., 1991) . The bacterial load in these samples would have been reduced following dilution and may have been beyond the range of the block-based primers. Additionally, some of the samples may have contained smaller sheared fragments of DNA resulting from sample preparation (e.g. paraffin-embedded tissues), which can result in shearing into fragments of ,650 bp following Qiagen extraction, and amplification with the block-based primers would therefore have been greatly reduced.
The inherent problem observed in amplification of the 16S rRNA gene is background contamination of reagents with low levels of bacteria, which can be co-amplified (Corless et al., 2000; Harris and Hartley, 2003) , and was observed in all assays. The LC assays were adapted for use on the LC from a SmartCycler method published by Kommedal et al. (2008) . The authors used the following definition: 'a positive sample was defined as a sample reaching the fluorescence threshold value (CP) ¢three cycles before the negative control and a sample was also defined as positive if it reached the CP fewer than three cycles before the negative control but if the subsequent melting curve analysis showed a single distinct peak clearly different from the negative control'. Both of these criteria were considered in this study, but the negative-control CP value showed considerable run-to-run variation and all samples were sequenced. This identified amplicons from 11 samples that would have been considered negative by the above criteria, but subsequent sequencing identified clinically relevant organisms. Analysis of the melting-curve data for these late-amplified samples did not reveal a melting curve that was significantly different from the negative controls and could not be used to differentiate these positive samples. In this study, the following criteria were used: all samples were sequenced regardless of CP, but caution was used with samples that amplified in less than three cycles from the negative control. In addition, samples that amplified after cycle 25 were used neat in subsequent sequencing reaction, and samples that amplified before cycle 25 were diluted 1 : 4 in the sequencing reaction, whilst melting-curve data were not used in the analysis and are no longer performed.
The background contamination of the reagents can also cause a problem with mixed-sequence traces. If the bacterial load of the clinically significant bacteria is sufficiently high, then it is preferentially amplified and the background contamination is not observed. However, when there are only low levels of clinically significant bacteria, then the background is co-amplified and a mixed trace can be observed. The master mix used for amplification with the block-based primers was different from that used for the LC, which requires a specialized master mix optimal for fast amplification. In this study, there were significantly more mixed traces detected using the block-based assay. The LC reagents do have a low level background contamination, as demonstrated by late amplification curves with high CP values in the negative controls; however, this was not amplified in sufficient amounts or was not composed of a dominant organism and so mixed-sequence traces were not observed. There were four extracts that showed mixed-sequence traces with all assays and represented genuine mixed bacterial infections. Specialized Taq enzymes and master mixes are available with a guaranteed low background DNA level. The use of these may improve the background contamination observed but will increase the cost of performing the assay.
There are a large number of publications on the use of 16S rRNA gene sequencing for bacterial identification, but there is no consensus on the optimal region of the gene to target. Therefore, it was important in this study to review the differences observed from amplifying and sequencing different regions. The Bosshard-based primers amplified the region spanning V1-V3, whereas the Kommedal-based primers amplified the region spanning V3-V4. The Bosshard-based primers performed slightly better than the Kommedal-based primers for both sensitivity and resolution. In the paper by Kommedal et al. (2009) (Kommedal et al., 2008; Harris & Hartley, 2003) , and these organisms represented the most prevalent organisms found in this study (Table 3) . Therefore, for the majority of samples, reducing the size of the region sequenced did not have a negative impact on identification, and it would be more beneficial to sequence alternative gene targets (e.g. rpoB or secA) rather than sequence a larger region of the 16S rRNA gene if species-level identification was clinically important. There were four samples where the V1-V3 region could not identify the organism to the genus level (Cetobacterium/Fusobacterium and Escherichia/Shigella species). E. coli and Shigella dysenteriae are genotypically close enough to be considered the same species but have been kept separate for clinical reasons (Clarridge, 2004) , and for the sample containing either Cetobacterium or Fusobacterium, a larger region of the 16S rRNA gene sequence is required to resolve these to the genus or species level, delaying the clinical result by 1-2 days.
Considerable work has already been undertaken to show the utility of 16S rRNA gene PCR and sequencing for identification of bacteria. It has been shown previously to be superior to phenotypic identification methods and nearly always results in an identification (Clarridge, 2004; Janda & Abbott, 2007) . The application for clinical samples and in particular culture-negative samples has also been demonstrated (Harris & Hartley, 2003; Kommedal et al., 2009) , as have the pitfalls of quality of sequence databases, contamination of reagents and lack of resolution for some genera. The work in this study was undertaken to establish whether using a real-time PCR-based approach would improve the sensitivity and speed of detection. We have demonstrated that amplification can easily be performed on the LC and that this approach offers a considerable improvement in sensitivity of detection. In our hands, it was relatively easy to differentiate amplification of infection-causing organisms against the background contamination of the reagents, and fewer mixed-sequence traces were observed. Amplification of a smaller region of the gene affected the resolution of the data but not significantly. Instead, it improved the sensitivity, allowed amplification from difficult sample types and improved the overall time taken to perform the analysis. Using this approach, it is possible to perform amplification and sequencing, leading to identification in ,24 h following extraction. It is also possible that, by employing different extraction methods and techniques, the overall time could be reduced further and the sensitivity of detection improved, offering an additional improvement for detection of bacteria directly from clinical samples.
